Alira Health Contributes to 2022 Bioregion Report on the Future of Catalan Life Sciences

News
Published on:
February 13, 2023

We are pleased to announce that we are a key contributor to the just released 2022 Bioregion Report, the benchmark study that analyzes the life sciences and healthcare sector in Catalonia, conducted by Biocat, BioRegion of Catalonia together with CataloniaBio & HealthTech and ACCIÓ. Our Market Access team aimed to analyze the main molecules that have entered the market based on innovation, and to identify those medical technology products that have accessed the market and how they have done so.

We were thrilled to contribute to the 2022 BioRegion Report, a one-of-a-kind in-depth analysis of the life sciences and biotechnology sector in Catalonia.
Chus Castillo Vice President Global Market Access Iberia, Alira Health

Some key findings from the report include –

  • Investment in startups and scaleups has exceeded all expectations in 2022, achieving 445 million euros in funding, boosted by the first mega round in the history of the BioRegion, captured by dental health medtech Impress, with 122 million euros.
  • Venture capital has once again been the primary source of financing, 95% of which involved international collaboration, followed by competitive grants (which have doubled compared to previous years), from the stock market, venture debt and crowdequity.
  • Financing from risk capital (venture capital) has once again been the main driver of this growth, accumulating 343 million euros, 77% of the total capital raised.
  • Foreign investment has also continued to hit record numbers. 95% of the total capital raised has included international investment companies. The number of international investment funds that have historically participated in operations has reached 117, a number that has doubled in the last three years.

This report was promoted at the presentation of the 2022 BioRegion Report on the 13th of February. The event was attended by institutional representatives of the Government of Catalonia and included a presentation of key indicators from the BioRegion Report and several expert round tables on innovation, investment and healthcare.

“We were thrilled to contribute to the 2022 BioRegion Report, a one-of-a-kind in-depth analysis of the life sciences and biotechnology sector in Catalonia. This report is a must-read for any stakeholder that is looking for a comprehensive overview of the activities of local companies, research facilities, and universities operating in the region. It provides a detailed view of the healthcare ecosystem in Catalonia as one of the leading regions in Europe in this sector,” said Chus Castillo, Vice President Global Market Access Iberia, Alira Health. “We hope that our contribution will enable healthcare companies to easily enter the Catalonian market and achieve maximum commercial success.”

Related news

Blog March 18, 2024
WHO Model Lists of Essential Medicines: What You Need to Know 
Our Market Access experts share the importance of the EML for pharma companies and four best practices for a successful application, based on our extensive experience in interactions with the WHO.
Market Access
Events February 20, 2024
World EPA Congress Europe
Look for market access and pricing experts Ahmad Bechara and Andrea Mantovani representing Alira Health on the agenda at World EPA Congress.
Market Access Pricing Real-World Evidence (RWE)
Events February 1, 2024
2023 BioRegion Report Presentation
Biotech Spain
News January 24, 2024
Alira Health and AseBio Announce Market Access Mentoring Program for 2024
Alira Health and AseBio, the Spanish Bioindustry Association, are pleased to announce the 2024 edition of their market access mentoring program for AseBio members.
Biotech Market Access Spain Startups
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
News January 18, 2024
Alira Health and Biocat Announce Startup Support Program for 2024
Alira Health and Biocat, a strategic stakeholder building the Catalan life sciences and ecosystem, partnered to foster Market Access for startups.
Market Access Startups
Events January 17, 2024
Presentation: Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain
On January 23rd we will present the results of the first phase of the “Pilot Project for the Inclusion of the Patient Voices in the Regional Market Access Drug Committees in Spain.”
Market Access Patient Engagement Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.